Thomas A. McCourt
CIK: 0001478448
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 11, 2026PLRX
PLIANT THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
70K shares- - Mar 10, 2026IRWD
IRONWOOD PHARMACEUTICALS INC
Award(A)Direct409.8K shares- - Feb 24, 2026IRWD
IRONWOOD PHARMACEUTICALS INC
Sale(S)Direct103.5K shares at avg. $3.66$379K - Feb 23, 2026IRWD
IRONWOOD PHARMACEUTICALS INC
Sale(S)Direct94.8K shares at avg. $3.81$361K - Jun 5, 2025PLRX
PLIANT THERAPEUTICS, INC.
Award(A)DirectCommon Stock (Right to Buy)
30K shares- - May 20, 2025IRWD
IRONWOOD PHARMACEUTICALS INC
Award(A)Direct540K shares- - May 16, 2025IRWD
IRONWOOD PHARMACEUTICALS INC
Sale(S)Direct13.4K shares at avg. $0.58$8K - Feb 10, 2025IRWD
IRONWOOD PHARMACEUTICALS INC
Sale(S)Direct139.1K shares at avg. $1.76$245K - Jan 17, 2025IRWD
IRONWOOD PHARMACEUTICALS INC
Award(A)Direct147.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  PLRX PLIANT THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 70,000 | - | - | Direct |
| Mar 10, 2026 |  IRWD IRONWOOD PHARMACEUTICALS INC | Award(A) | 409,836 | - | $0 | Direct |
| Feb 24, 2026 | IRWD IRONWOOD PHARMACEUTICALS INC | Sale(S) | 103,526 | $3.66 | $378,905 | Direct |
| Feb 23, 2026 | IRWD IRONWOOD PHARMACEUTICALS INC | Sale(S) | 94,757 | $3.81 | $361,024 | Direct |
| Jun 5, 2025 | PLRX PLIANT THERAPEUTICS, INC. | Award(A) Common Stock (Right to Buy) | 30,000 | - | - | Direct |
| May 20, 2025 | IRWD IRONWOOD PHARMACEUTICALS INC | Award(A) | 540,000 | - | - | Direct |
| May 16, 2025 | IRWD IRONWOOD PHARMACEUTICALS INC | Sale(S) | 13,353 | $0.58 | $7,745 | Direct |
| Feb 10, 2025 | IRWD IRONWOOD PHARMACEUTICALS INC | Sale(S) | 139,064 | $1.76 | $244,753 | Direct |
| Jan 17, 2025 | IRWD IRONWOOD PHARMACEUTICALS INC | Award(A) | 147,354 | - | $0 | Direct |
1-9 of 9 transactions
About MCCOURT Thomas A
MCCOURT Thomas A (SEC CIK 0001478448) files insider reports with the SEC as Director of PLIANT THERAPEUTICS, INC. (PLRX) and Chief Executive Officer of IRONWOOD PHARMACEUTICALS INC (IRWD).
Signal8 holds 7 ownership filings by MCCOURT Thomas A, all Form 4s, filed between Jan 22, 2025 and Jun 12, 2026. Those filings report 9 transactions, from Jan 17, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on MCCOURT Thomas A's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by MCCOURT Thomas A
- Jun 11, 2026: Grant or award of PLRX derivative securities (Form 4, code A).
- Mar 10, 2026: Grant or award of IRWD shares (Form 4, code A).
- Feb 24, 2026: Open-market sale of IRWD shares (Form 4, code S).
- Feb 23, 2026: Open-market sale of IRWD shares (Form 4, code S).
- Jun 5, 2025: Grant or award of PLRX derivative securities (Form 4, code A).
Other insiders filing for PLIANT THERAPEUTICS, INC. (PLRX)
- Raben David, Chief Medical Officer
- Iannone Robert, Director
- Borellini Flavia, Director
- CROWELL GAYLE A, Director
- Krognes Steve E., Director
- Curnutte John T, Director